Dr Denese Marks

Adjunct Associate Professor
Medicine (Immunology &
Infectious Diseases), Central Clinical School
Australian Red Cross Blood Service

Telephone 92342369

Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Loh, Y., Johnson, L., Kwok, M., Marks, D. (2014). Pathogen reduction treatment alters the immunomodulatory capacity of buffy coat-derived platelet concentrates. Transfusion, 54(3), 577-584. [More Information]
  • Johnson, L., Coorey, C., Marks, D. (2014). The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine-expressing platelets and platelet microparticles. Transfusion, 54(8), 1917-1926. [More Information]
  • Johnson, L., Winter, K., Kwok, M., Reid, S., Marks, D. (2013). Evaluation of the quality of blood components prepared using the Reveos automated blood processing system. Vox Sanguinis, 105(3), 225-235. [More Information]
  • Johnson, L., Loh, Y., Kwok, M., Marks, D. (2013). In vitro assessment of buffy-coat derived platelet components suspended in SSP+ treated with the INTERCEPT Blood system. Transfusion Medicine (Online), 23(2), 121-129. [More Information]
  • Johnson, L., Reid, S., Tan, S., Vidovic, D., Marks, D. (2013). PAS-G supports platelet reconstitution after cryopreservation in the absence of plasma. Transfusion, 53(10), 2268-2277. [More Information]
  • Tran, V., Marks, D., Duke, R., Bebawy, M., Duke, C., Roufogalis, B. (2011). Modulation of P-glycoprotein-Mediated Anticancer Drug Accumulation, Cytotoxicity, and ATPase Activity by Flavonoid Interactions. Nutrition and Cancer: an international journal, 63(3), 435-443. [More Information]

2014

  • Loh, Y., Johnson, L., Kwok, M., Marks, D. (2014). Pathogen reduction treatment alters the immunomodulatory capacity of buffy coat-derived platelet concentrates. Transfusion, 54(3), 577-584. [More Information]
  • Johnson, L., Coorey, C., Marks, D. (2014). The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine-expressing platelets and platelet microparticles. Transfusion, 54(8), 1917-1926. [More Information]

2013

  • Johnson, L., Winter, K., Kwok, M., Reid, S., Marks, D. (2013). Evaluation of the quality of blood components prepared using the Reveos automated blood processing system. Vox Sanguinis, 105(3), 225-235. [More Information]
  • Johnson, L., Loh, Y., Kwok, M., Marks, D. (2013). In vitro assessment of buffy-coat derived platelet components suspended in SSP+ treated with the INTERCEPT Blood system. Transfusion Medicine (Online), 23(2), 121-129. [More Information]
  • Johnson, L., Reid, S., Tan, S., Vidovic, D., Marks, D. (2013). PAS-G supports platelet reconstitution after cryopreservation in the absence of plasma. Transfusion, 53(10), 2268-2277. [More Information]

2011

  • Tran, V., Marks, D., Duke, R., Bebawy, M., Duke, C., Roufogalis, B. (2011). Modulation of P-glycoprotein-Mediated Anticancer Drug Accumulation, Cytotoxicity, and ATPase Activity by Flavonoid Interactions. Nutrition and Cancer: an international journal, 63(3), 435-443. [More Information]

To update your profile click here. For support on your academic profile contact .